The purpose of this study was to evaluate the outcomes in breast reconstruction combining lower abdominal flaps with implants and to compare the impact of timing of implant placement on complication and revision rates. Methods: A retrospective review of all patients who underwent free transverse rectus abdominis musculocutaneous, muscle-sparing transverse rectus abdominis musculocutaneous, deep inferior epigastric perforator, or superficial inferior epigastric perforator flaps with implants at a single center over the past decade was performed. Patients were classified as having implant placement at the time of flap reconstruction or during a second procedure. The flap types, implant types/planes, flap and implant-related complications, and revision rates were compared between the groups. Results: Sixty-nine patients underwent 110 abdominal free flap breast reconstructions with an implant (immediate placement group, 35 patients; staged placement group, 34 patients). The mean follow-up periods were 32 months and 43 months for the immediate placement and staged placement groups, respectively. There was no statistically significant difference in flap type, implant type or plane, flap-related complications, or early implant-related complications between groups. The immediate placement group had a significantly higher rate of late implant-related complications: 25 percent (15 of 59) versus 4 percent (two of 51) in the staged placement group (p ϭ 0.007). The implant revision rate was 63 percent (22 of 35) in the immediate placement group versus 26 percent (nine of 34) in the staged placement group (p ϭ 0.081).
M
any women who undergo mastectomy desire autologous-tissue reconstruction, which is generally considered to provide the optimal appearance and feel of reconstructed breasts. 1 The goal of breast reconstruction is to recreate a natural-appearing breast that meets the patient's overall expectations in terms of aesthetics and size. Refinements in lower abdominal flap reconstructions have enabled reconstructed breasts to achieve the shape, texture, and ptosis of natural breasts. Often, the desired volume of the reconstructed breast(s) can be achieved with autologous tissue alone; however, a subset of women has inadequate abdominal tissue to meet their reconstructive goals. This subset includes very thin women and many women who choose to undergo bilateral breast reconstruction. 2 In addition, previous abdominal surgery can limit flap volume by the presence of a vertical midline scar or a superiorly oriented Pfannenstiel incision that can obliterate lower perforators.
Historically, postmastectomy reconstructions in women with inadequate autologous tissue were per-formed using a tissue expander or latissimus dorsi flap with implant. 3 Another option, however, is to place a silicone-or saline-filled implant beneath a lower abdominal flap. This option avoids the protracted course required for tissue expansion and the scarring at the latissimus dorsi flap donor site that many patients find unappealing. In addition, many patients derive satisfaction from the improvements in abdominal contour that can result from abdominal flap transfer. 4 The combination of implants with abdominal flaps has been described previously in small series; however, published data on the risks and benefits of such reconstructions are limited, and few studies have addressed the optimal timing of implant placement, which can be performed either at the time of flap reconstruction or during a second operation. 4 -7 We evaluated the outcomes in 69 patients who underwent abdominal free flap breast reconstruction with initial or staged implant placement.
PATIENTS AND METHODS
A retrospective review of all patients who underwent reconstruction of one or both breasts with an autologous lower abdominal free flap with a permanent implant at the University of Texas M. D. Anderson Cancer Center between 1998 and 2008 was performed. Patients who underwent reconstruction with a lower abdominal free flap and a tissue expander were not included in this analysis. Data regarding the patients, surgical procedures, and postoperative complications were collected from a prospectively maintained department database in which demographic, clinical, surgical, and outcome variables are entered and updated on an ongoing basis. This study was approved by our institutional review board.
For each patient identified, we extracted data on patient age, body mass index, and smoking status; history of prior breast augmentation; reason for mastectomy; timing of flap reconstruction (immediate versus delayed) relative to mastectomy; type of flap [free transverse rectus abdominis musculocutaneous (TRAM), muscle-sparing TRAM, superficial inferior epigastric artery, or deep inferior epigastric perforator (DIEP) flap]; recipient vessels; implant volume, type, texture, plane (subpectoral versus prepectoral), and timing of placement relative to flap reconstruction; type, timing, and treatment of complications; use of radiation therapy; and revisional procedures performed. Patients were classified as having implant placement at the time of flap reconstruction (immediate placement) or during a second operation (staged placement) ( Figs. 1 and 2) .
The primary endpoint of interest was the development of one or more complications related to the flap or implant that required operative intervention to resolve. Complications were categorized as early (Ͻ30 days after surgery) or late (Ն30 days after surgery). Flap-related complications included flap loss, fat necrosis, and mastectomy skin necrosis. Implant-related complications included periprosthetic infection, hematoma, implant malposition, capsular contracture, rippling, and implant rupture. Patients were evaluated by age, body mass index, smoking status, history of previous breast implants, and follow-up interval.
Descriptive statistics were calculated for each of the two groups (immediate placement and staged placement) and the entire data set. We used Fisher's exact test to assess associations between the timing of implant placement and implant plane and type, early and late complications, revision rate, and change in implant type/size. All tests were two-tailed. A value of p Ͻ 0.05 was considered statistically significant. Statistical analysis was performed using GraphPad Software (San Diego, Calif.).
RESULTS
Over an 11-year period, a total of 110 breast reconstructions combining lower abdominal flaps and implants were performed in 69 patients. Thirtyfive patients underwent implant placement at the time of flap reconstruction (immediate placement group), and 34 patients underwent implant placement during a second procedure (staged placement group). The mean time to implant placement in the staged placement group was 22.7 months (range, 2.6 to 138 months). The median age was 49 years (range, 28 to 64 years) in the immediate placement group and 47 years (range, 34 to 67 years) in the staged placement group. Among the 35 patients in the immediate placement group, 11 patients underwent unilateral reconstruction and 24 underwent bilateral reconstruction. In the staged placement group, 17 patients each underwent unilateral and bilateral reconstructions. The mean follow-up was 32 months in the immediate placement group and 43 months in the staged placement group. There was no significant difference in the demographic variables of age, body mass index, smoking, or history of previous implant between groups. The mean body mass index was 23.5 (range, 18.8 to 28.3) in the immediate placement group and 24.7 (range, 17.5 to 36.5) in the staged placement group. Volume 126, Number 2 • Lower Abdominal Flaps and Implants dence of radiation therapy were comparable in the two groups.
Data on the implant procedures are summarized in Table 2 . The access for implant placement in the immediate placement group was through the periareolar mastectomy incision in both skin-sparing and non-skin-sparing mastectomies. In the staged placement group, the access incision used was an inframammary incision in both delayed and previ- icone implants were more commonly used in the staged placement group [13 of 51 (25 percent)] than in the immediate placement group [five of 59 (8 percent) (p ϭ 0.073). The mean implant volumes were similar in the immediate placement and staged placement groups (179.5 ml and 183.5 ml, respectively).
Flap-related complications were comparable in the two groups (Table 3 ). There were no total flap losses in any of the reconstructions. Internal mammary vessels were preferentially used in both the immediate placement and staged placement groups. The plane of implant placement varied by surgeon preference, with the subpectoral planes favored in both the immediate placement and staged placement groups to insulate the implant from the vascular pedicle. Given this vessel selection and implant configuration, there was one pedicle injury in the staged placement group involving the internal mammary recipient vessels in an irradiated chest wall that resulted in a partial flap loss. The incidence of mastectomy flap necrosis was also similar in the groups [immediate placement group, three of 59 (5 percent); staged placement, three of 51 (6 percent)], as was the incidence of fat necrosis (immediate placement group, four of 59 (7 percent); staged placement group, five of 51 (10 percent)].
The immediate placement group had a higher overall incidence of implant-related complications that required operative intervention than did the staged placement group (32 percent versus 8 percent; p ϭ 0.0108) ( Table 4) . When early (Ͻ30 days) and late implant-related complications were considered separately, we found that the rates of early complications-hematoma, infection, and implant malposition-were similar in the immediate placement and staged placement groups (7 percent versus 4 percent; p ϭ 0.686). However, late complications, including infection, implant malposition, capsular contracture, rippling, and implant rupture, were more common in the immediate placement group (25 percent) than in the staged placement group (4 percent; p ϭ 0.007). Implant rupture occurred in 8 percent of reconstructions in the immediate placement group, whereas there were no implant failures encountered in the staged placement group (p ϭ 0.0650).
Revisions were more commonly performed in the immediate placement group, with 22 patients (63 percent) undergoing a surgical revision for reasons other than management of a complication; in the staged placement group, nine patients (26 percent) underwent a revision (p ϭ 0.081) ( Table 5 ). Six patients (17 percent) in the immediate placement group had their implants exchanged from saline to silicone, whereas none of the patients in the staged placement group un- Seventeen patients (49 percent) in the immediate placement group underwent a change in implant volume: 12 had an increase in volume by a mean of 81 ml (range, 35 to 250 ml), and five had a decrease in volume by a mean of 39 ml (range, 25 to 60 ml). In the staged placement group, only five patients (15 percent) (p ϭ 0.046 versus immediate placement group size changes) underwent a change in implant volume, and all had increases by a mean of 58 ml (range, 25 to 100 ml).
DISCUSSION
The technique of combining an abdominal flap with an implant has been described previously. [4] [5] [6] [7] However, whether the timing of implant placement relative to flap reconstruction affects complications has not been evaluated in a large patient cohort. In our series, flap-related complication rates were comparable in the immediate placement group and staged placement group, implying that the addition of an implant in the immediate placement group did not increase early postoperative morbidity from lower abdominal flap reconstruction. The incidence of fat necrosis, mastectomy flap necrosis, and flap failure did not increase in the presence of an implant, despite greater tension on the overlying flap and native mastectomy skin. We also found that the selection of recipient vessels and plane of implant placement were not influenced by the timing of implant placement, nor were they major determinants of flap-related complications. In addition, there was no difference in partial flap loss or fat necrosis outcomes between musculocutaneous flaps and perforator flaps. Thus, the addition of an implant at the time of free flap reconstruction can be safely performed with a multitude of perforator flaps, recipient vessels, and implant plane configurations.
Our findings also indicate that the timing of implant placement does not impact implant-related complications in the early postoperative period. Our overall incidence of early hematoma, implant infection, and implant malposition complications was 5 percent, which is comparable to that reported in the literature. 8 However, as these patients underwent long-term follow-up, it became apparent that those patients who had their implants placed at the time of flap reconstruction were more likely to develop late complications requiring surgical revision than were patients who had their implants placed during a second procedure. These implant-related complications likely arose from the scale and duration of the flap surgery. The higher infection, implant malposition, and capsular contracture rates in the immediate placement group were likely attributable to unrecognized implant contamination, subclinical seroma/hematoma, and the difficulty of creating a precise implant pocket at the time of mastectomy and flap reconstruction. The cause of the higher (though not significantly higher) implant rupture rate seen in the immediate placement group is unclear. The majority of the implants failed within the first 27 months, which points to some form of iatrogenic cause. All the ruptured implants were saline-filled; however, silicone implant ruptures Their review of complication rates in the immediate and delayed implant groups were in agreement with the findings in our larger series. In the immediate implant group, three patients (18 percent) developed partial flap loss and three patients (18 percent) developed a periprosthetic infection requiring implant removal; however, these complications were not encountered in the delayed implant group. In 2007, Figus et al. reported similar findings for 14 patients who underwent 18 combined DIEP flap and silicone implant reconstructions (14 immediate implant and four delayed implant reconstructions). 9 The authors described a trend toward a higher complication rate in the immediate group with two partial flap losses but no major complications in the delayed group.
Given the small number of patients in previous reports, we set out to evaluate which approach to the timing of implant placement has a lower incidence of complications and a more predictable outcome in a large cohort of patients. Although early complication rates were similar in the immediate placement and staged placement groups, there was a statistically significant increase (p ϭ 0.007) in the rate of late complications in the immediate placement group (Ͼ30 days). This suggests that lower abdominal flap reconstruction with implant augmentation is safer in the long term when performed in a staged fashion.
In addition, in our series, there was a trend toward an increased number of revisions in the immediate placement group. The need for revision was attributable to the patient's perception of asymmetry (in volume or shape) of the breasts. When combining lower abdominal flaps with implants, a staged approach is preferable, as it enables the surgeon to minimize the impact of the variables of breast envelope edema and widely undermined anatomical borders of the breast at the time of mastectomy. Delayed implant placement allows more control and precision in creating an implant pocket and estimating the implant size since the breast flap envelope has stabilized.
Patients with inadequate abdominal flap volume who need to augment their breast reconstruction with an implant are encountered relatively infrequently when compared with the total number of patients who undergo breast reconstruction with an abdominal free flap. Overall, 2252 patients underwent abdominal free flap breast reconstruction at the University of Texas M. D. Anderson Cancer Center between 1998 and 2008, whereas only 69 patients (3.1 percent) underwent combined implant/abdominal flap reconstructions. It is unclear whether abdominal flap/implant reconstruction will continue to gain popularity and become as commonly performed as latissimus dorsi flap/implant reconstruction. However, using a TRAM flap or other abdominal flap instead of a latissimus dorsi flap has some potential advantages. Larger skin paddles are more readily available in the abdomen than in the back. This is particularly important for mastectomy defects that include large skin defects; ample skin replacement is essential to achieving desired projection and ptosis in the reconstructed breast. Also, the thicker adipocutaneous tissue of the abdomen does not undergo atrophy like that of a latissimus dorsi myocutaneous flap; thus, there is less volume loss over time with a TRAM/implant combination than with a latissimus dorsi/implant. Furthermore, a smaller volume implant is typically needed in TRAM/implant reconstruction than in latissimus dorsi/implant reconstruction because more of the total volume of the reconstruction comes from the TRAM flap itself. This results in a better aesthetic outcome, as a smaller implant under a TRAM flap is better insulated and less likely to display upper pole rippling.
The strengths of this study include strict inclusion criteria to establish the two groups for comparison, a relatively large number of patients, and a greater than 3-year mean follow-up period. Despite the strict inclusion and exclusion criteria, this retrospective study has some limitations. Patients were Volume 126, Number 2 • Lower Abdominal Flaps and Implants not randomly assigned to implant placement at the time of flap reconstruction or at a second procedure. The decision regarding timing of implant placement, implant plane, and implant type was based on surgeon preference. All patients in the immediate placement group had the decision to include an implant finalized in the operating room at the time of the procedure, whereas the decision to increase flap volume with an implant was made preoperatively in the staged placement group. This might have resulted in some selection bias: the decision to place an implant at the time of flap reconstruction if conditions were ideal and to defer implant placement to a second procedure in cases where there was a concern with mastectomy skin viability, potential flap compromise, or inability to adequately estimate appropriate volume for symmetry. This potential bias toward deciding against immediate placement of an implant at the time of flap reconstruction should in theory lead to a decreased number of complications in the immediate placement group. The higher complication rate in the immediate placement group, despite a selection bias in this group to place implants only under ideal circumstances, further supports the benefits of staged implant placement.
Placing an implant at the time of flap reconstruction has several potential disadvantages. There is a great degree of estimation required in the surgeon's selection of the proper implant size, because the patient has not had an opportunity to appreciate the size of the breast created with the flap alone. Also, immediate implant placement is more technically difficult than delayed placement in that the surgeon has to design an optimal flap inset and place the implant in such a way as not to compromise the flap perforators or pedicle. Lastly, with immediate implant placement, there is the possibility of a subclinical hematoma or seroma that can compromise the implant through periprosthetic infection and capsular contracture. Delayed implant placement, in contrast, can be performed as an outpatient procedure, much like a breast augmentation. The patient has the opportunity to evaluate the size and shape of the flap-reconstructed breast so that a more accurate decision can be made regarding the implant volume and profile. This is most important, as the patient is involved in the decision making and planning of this procedure, which influences satisfaction with outcome.
CONCLUSIONS
We conclude that it is safe to combine implants with autologous lower abdominal free flaps for postmastectomy breast reconstructions with regard to 
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